Abstract Body

Background

Weight gain has been reported with integrase inhibitors in HIV treatment, raising concerns for long-acting cabotegravir (CAB-LA) used in HIV prevention. In treatment settings, removal of TDF has also been linked to weight increases, suggesting that switching from daily oral PrEP with TDF/FTC to CAB-LA could alter weight trajectories. 

Methods

We analyzed a prospective cohort initiating CAB-LA for PrEP. Weight and BMI were measured at each injection visit. Participants were classified as PrEP-naive or Switchers (on TDF/FTC at CAB-LA initiation). Absolute (kg), relative (%) and BMI changes were calculated from first to latest available dose, and standardized analyses were performed from dose 1 → dose 4. Between-group differences were assessed with Welch’s t-test and Mann–Whitney U.

Results

A total of 171 individuals initiated CAB-LA for PrEP, including 147 (86%) who were taking daily TDF/FTC at initiation (Switchers) and 24 (14%) who were PrEP-naive. Among CAB-LA users, 165 (96%) completed follow-up through the 4th injection (141 Switchers and 24 PrEP-naive). From dose 1 to the latest available injection, mean Δweight was +0.32 kg (SD 2.8) in Switchers and –0.25 kg (SD 3.2) in PrEP-naive, corresponding to mean %Δweight of +0.5% and –0.3%, respectively (p=0.41). Between dose 1 and dose 4, mean Δweight was +0.3 kg (range –9 to +12) among Switchers and –0.3 kg (range –10 to +5) among PrEP-naive, with a median Δweight of 0.0 kg in both groups (p=0.53). Changes in BMI (ΔBMI) were minimal, and weight trajectories across doses 1–4 remained flat with overlapping standard errors, indicating no divergence between groups.

Conclusions

Up to the 4th CAB-LA injection, weight remained stable, with no clinically meaningful gain observed in either PrEP-naive initiators or those switching from daily TDF/FTC. The absence of divergence between groups suggests that switching from oral PrEP does not modify weight outcomes under CAB-LA. Longer-term follow-up, particularly in PrEP-naive populations, is needed to confirm these findings.

Table or Figure